Showing results (161-170 of 174) with videos related to
Sort By:
Pageof 18
Archives of Toxicology|August 13, 2022
Hypoalbuminemia affects the spatio-temporal tissue distribution of ochratoxin A in liver and kidneys: consequences for organ toxicityReham Hassan, Adrian Friebel, Lisa Brackhagen, et al.Liver International : Official Journal of the International Association for the Study of the Liver|January 20, 2026
GDF-15 Levels in Cirrhosis Are Linked to Hepatic Fibrogenesis, Bacterial Translocation, and Worse Clinical OutcomesBenedikt Silvester Hofer, Thomas Perkmann, Ksenia Brusilovskaya, et al.United European Gastroenterology Journal|December 7, 2021
Hepatitis D virus (HDV) prevalence in Austria is low but causes considerable morbidity due to fast progression to cirrhosisMathias Jachs, Teresa Binter, Caroline Schmidbauer, et al.Hepatology (Baltimore, Md.)|July 30, 2024
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.Hepatology (Baltimore, Md.)|January 16, 2025
Long-term outcome and risk stratification in compensated advanced chronic liver disease after HCV-cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.Liver International : Official Journal of the International Association for the Study of the Liver|October 1, 2024
A systematic PCR record-based re-call of HCV-RNA-positive people enables re-linkage to care and HCV elimination in Austria - The ELIMINATE projectLorenz Balcar, Michael Schwarz, Livia Dorn, et al.JHEP Reports : Innovation in Hepatology|December 9, 2025
Pre-emptive TIPS should be considered in high-risk patients with both acute variceal bleeding and severe alcohol-related hepatitisMarika Rudler, Virginia Hernandez Gea, Hélène Larrue, et al.Journal of Hepatology|March 23, 2024
Post-treatment LSM rather than change during treatment predicts decompensation in patients with cACLD after HCV cureGeorg Semmler, Sonia Alonso López, Monica Pons, et al.Wiener Klinische Wochenschrift|September 29, 2023
ELIMINATE: a PCR record-based macroelimination project for systematic recall of HCV-RNA-positive persons in AustriaCaroline Schwarz, David Bauer, Livia Dorn, et al.Nature Communications|September 12, 2022
Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trialDaniel Mrak, Daniela Sieghart, Elisabeth Simader, et al.Pageof 18